Clinical trial
A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males
NCT04183517 is registered in ClinicalTrials.gov with Syntara as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males
- Lead sponsor
- Syntara
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 20, 2019
- Completion date
- June 24, 2020
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pharmacokinetics